Skip to content
Operating Expenses

Policyholder Benefits And Claims Incurred Net

CVS Health Policyholder Benefits And Claims Incurred Net decreased by 11.2% to $29.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.8%, from $29.14B to $29.36B. Over 3 years (FY 2022 to FY 2025), Policyholder Benefits And Claims Incurred Net shows an upward trend with a 20.9% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2016
Last reportedQ1 2026May 6, 2026
Metric ID: operating_expenses_policyholder_benefits_and_claims_incu_84f983

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$17.77B$17.77B$17.77B$17.77B$20.45B$21.78B$21.5B$22.52B$27.8B$27.85B$29.92B$29.54B$29.14B$31.32B$32.02B$33.07B$29.36B
QoQ Change+0.0%+0.0%+0.0%+15.1%+6.5%-1.3%+4.7%+23.5%+0.2%+7.4%-1.3%-1.4%+7.5%+2.2%+3.3%-11.2%
YoY Change+15.1%+22.6%+21.0%+26.7%+36.0%+27.9%+39.2%+31.2%+4.8%+12.4%+7.0%+11.9%+0.8%
Range$17.77B$33.07B
CAGR+13.4%
Avg YoY Growth+19.7%
Median YoY Growth+21.0%

Business Segments

View all
SegmentQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health Care Benefits$28.64B$30.74B$31.32B$32.25B$28.58B
Health Services$1.05B$1.1B$1.29B$1.4B$1.3B
Corporate/ Other$46M$40M$47M$44M$46M
Pharmacy & Consumer Wellness$0$0$0$0$0
Total$29.14B$31.32B$32.02B$33.07B$29.36B

Frequently Asked Questions

What is CVS Health's policyholder benefits and claims incurred net?
CVS Health (CVS) reported policyholder benefits and claims incurred net of $29.36B in Q1 2026.
How has CVS Health's policyholder benefits and claims incurred net changed year-over-year?
CVS Health's policyholder benefits and claims incurred net increased by 0.8% year-over-year, from $29.14B to $29.36B.
What is the long-term trend for CVS Health's policyholder benefits and claims incurred net?
Over 3 years (2022 to 2025), CVS Health's policyholder benefits and claims incurred net has grown at a 20.9% compound annual growth rate (CAGR), from $71.07B to $125.54B.